Serum levels of IL-8 and IL-6 in the long term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study

International Immunopharmacology

Volumn 9, Issue 13-14, 2009, Pages 1482-1488

  Pourfarzam, Shahryar ^a   Ghazanfari, Tooba ^a   Yaraee, Roya ^a   Ghasemi, Hassan ^a   Hassan, Zuhair M ^b   Faghihzadeh, Soghrat ^b   Ardestani, Sussan K ^c   Kariminia, Amina ^d   Fallahi, Faramarz ^a   Soroush, Mohammad R ^e   Merasizadeh, Javad ^f   Mahlojirad, Maryam ^g   Naghizadeh, Mohammad M ^a,h   Ghanei, Mostafa ^f  

^a SHAHED UNIVERSITY   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e JANBAZAN MEDICAL AND ENGINEERING RESEARCH CENTER JMERC   (Iran)

^f BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h FASA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytokine; IL 6; IL 8; Inflammatory mediators; Iran; Mustard gas; Pulmonary

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MUSTARD GAS; RHEUMATOID FACTOR;

ABNORMAL RESPIRATORY SOUND; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; COUGHING; CRACKLES; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOPTYSIS; HUMAN; IRAN; LONG TERM EXPOSURE; LUNG COMPLICATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PHOTOMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RALES; SMOKING; SPIROMETRY; SPUTUM; WHEEZING;

C-REACTIVE PROTEIN; CHEMICAL WARFARE AGENTS; COHORT STUDIES; COUGH; DYSPNEA; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; IRAN; MUSTARD GAS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RESPIRATORY SOUNDS; RHEUMATOID FACTOR; TIME FACTORS;

EID: 70350566704     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.09.002     Document Type: Article

References (49)

1. Ghasemi H., Ghazanfari T., Babaei M., Soroush M., Yaraee R., Ghassemi-Broumand M., et al. Long-term ocular complications of sulfur mustard in the civilian victims of Sardasht, Iran. Cutan Ocul Toxicol 27 4 (2008) 317-326
2. Ghasemi H., Ghazanfari T., Yaraee R., Soroush M.R., Ghassemi-Broumand M., Pourfarzam Sh., et al. Systemic and ocular complications of sulfur mustard: a panoramic review. Toxin Rev 28 1 (2009) 14-23
3. Ghazanfari T., Hassan Z.M., and Foroutan A. The long-term consequences of sulfur mustard on Iranian chemical victims: introduction. Toxin Rev 28 1 (2009) 1-2
4. Moin A., Ghazanfari T., Davoudi S.M., Emadi N., Panahi Y., Hassan Z.M., et al. Long-term skin findings of sulfur mustard exposure on the civilians of Sardasht, Iran. Toxin Rev 28 1 (2009) 24-29
5. Ghassemi Broumand M., Karamy G.H., Pourfarzam Sh., Emadi S.N., and Ghassemi H. Late occurrence of ophthalmic, respiratory, cutaneous and psychiatric complications of chemical weapons exposure in 479 war patients. Daneshvar Med 70 70 (2007) 81-92
6. Pourfarzam S., Ghazanfari T., Merasizadeh J., Ghanei M., Azimi G., Araghizadeh H., et al. Long-term pulmonary complications in sulfur mustard victims of Sardasht, Iran. Toxin Rev 28 1 (2009 Feb 1) 8-13
7. Baggiolini M., Dewald B., and Moser B. Human chemokines: an update. Annu Rev Immunol 15 (1997) 675-705
8. Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 72 4 (2000 Dec) 391-398
9. Matsushima K., Morishita K., Yoshimura T., Lavu S., Kobayashi Y., Lew W., et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 167 6 (Jun 1 1988) 1883-1893
10. Aihara M., Tsuchimoto D., Takizawa H., Azuma A., Wakebe H., Ohmoto Y., et al. Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect Immun 65 8 (Aug 1997) 3218-3224
11. Kunz M., Hartmann A., Flory E., Toksoy A., Koczan D., Thiesen H.J., et al. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am J Pathol 155 3 (Sep 1999) 753-763
12. Mukaida N. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 284 4 (Apr 2003) L566-L577
13. Car B.D., Meloni F., Luisetti M., Semenzato G., Gialdroni-Grassi G., and Walz A. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 149 3 Pt 1 (Mar 1994) 655-659
14. Nocker R.E., Schoonbrood D.F., van de Graaf E.A., Hack C.E., Lutter R., Jansen H.M., et al. Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 109 2 (Feb 1996) 183-191
15. Danilko K.V., Korytina G.F., Akhmidishina L.Z., Ianbaeva D.G., Zagidullin S., and Victorova T.V. Association of cytokines genes (ILL, IL1RN, TNF, LTA, IL6, IL8, IL0) polymorphic markers with chronic obstructive pulmonary disease. Mol Biol (Mosk) 41 1 (Jan 2007) 26-36
16. Lee T.M., Lin M.S., and Chang N.C. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol 101 4 (Feb 15 2008) 530-535
17. Thorleifsson S.J., Margretardottir O.B., Gudmundsson G., Olafsson I., Benediktsdottir B., Janson C., et al. Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland. Respir Med (May 6 2009)
18. Higashimoto Y., Iwata T., Okada M., Satoh H., Fukuda K., and Tohda Y. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med 103 8 (Aug 2009) 1231-1238
19. Sakaida H. IgG rheumatoid factor in rheumatoid arthritis with interstitial lung disease. Ryumachi 35 4 (Aug 1995) 671-677
20. Coffey M., Hassan J., Feighery C., Fitzgerald M., and Bresnihan B. Rheumatoid factors in cystic fibrosis: associations with disease manifestations and recurrent bacterial infections. Clin Exp Immunol 77 1 (Jul 1989) 52-57
21. Sabourin C.L., Danne M.M., Buxton K.L., Casillas R.P., and Schlager J.J. Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J Biochem Mol Toxicol 16 6 (2002) 263-272
22. Tsuruta J., Sugisaki K., Dannenberg Jr. A.M., Yoshimura T., Abe Y., and Mounts P. The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard. Inflammation 20 3 (Jun 1996) 293-318
23. Emad A., and Emad Y. Levels of cytokine in bronchoalveolar lavage (BAL) fluid in patients with pulmonary fibrosis due to sulfur mustard gas inhalation. J Interferon Cytokine Res 27 1 (Jan 2007) 38-43
24. Ghazanfari T., Faghihzadeh S., Aragizadeh H., Soroush M.R., Yaraee R., Hassan Z.M., et al. Sardasht-Iran Cohort Study of chemical warfare victims: design and methods. Arch Iran Med 12 1 (Jan 2009) 5-14
25. Khateri S., Ghanei M., Keshavarz S., Soroush M., and Haines D. Incidence of lung, eye, and skin lesions as late complications in 34, 000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45 11 (Nov 2003) 1136-1143
26. Ziegenhagen M.W., Zabel P., Zissel G., Schlaak M., and Muller-Quernheim J. Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. Am J Respir Crit Care Med 157 3 Pt 1 (Mar 1998) 762-768
27. Gerritsen W.B., Asin J., Zanen P., van den Bosch J.M., and Haas F.J. Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients. Respir Med 99 1 (Jan 2005) 84-90
28. Perera W.R., Hurst J.R., Wilkinson T.M., Sapsford R.J., Mullerova H., Donaldson G.C., et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 29 3 (Mar 2007) 527-534
29. Silvestri M., Bontempelli M., Giacomelli M., Malerba M., Rossi G.A., Di S.A., et al. High serum levels of tumour necrosis factor-alpha and interleukin-8 in severe asthma: markers of systemic inflammation?. Clin Exp Allergy 36 11 (Nov 2006) 1373-1381
30. Betz R., Kohlhaufl M., Kassner G., Mullinger B., Maier K., Brand P., et al. Increased sputum IL-8 and IL-5 in asymptomatic nonspecific airway hyperresponsiveness. Lung 179 2 (2001) 119-133
31. Chung K.F. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 34 (Dec 2001) 50s-59s
32. Franciosi L.G., Page C.P., Celli B.R., Cazzola M., Walker M.J., Danhof M., et al. Markers of disease severity in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 19 3 (2006) 189-199
33. Hollander C., Sitkauskiene B., Sakalauskas R., Westin U., and Janciauskiene S.M. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma. Respir Med 101 9 (Sep 2007) 1947-1953
34. Keatings V.M., Collins P.D., Scott D.M., and Barnes P.J. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 153 2 (Feb 1996) 530-534
35. Sakito O., Kadota J., Kohno S., Abe K., Shirai R., and Hara K. Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration 63 1 (1996) 42-48
36. Ghanei M., Moqadam F.A., Mohammad M.M., and Aslani J. Tracheobronchomalacia and air trapping after mustard gas exposure. Am J Respir Crit Care Med 173 3 (Feb 1 2006) 304-309
37. DiGiovine B., Lynch III J.P., Martinez F.J., Flint A., Whyte R.I., Iannettoni M.D., et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. J Immunol 157 9 (Nov 1 1996) 4194-4202
38. Elssner A., Jaumann F., Dobmann S., Behr J., Schwaiblmair M., Reichenspurner H., et al. Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group. Transplantation 70 2 (Jul 27 2000) 362-367
39. Koh Y.Y., Jung D.E., Koh J.Y., Kim J.Y., Yoo Y., and Kim C.K. Bronchoalveolar cellularity and interleukin-8 levels in measles bronchiolitis obliterans. Chest 131 5 (May 2007) 1454-1460
40. Zheng L., Walters E.H., Ward C., Wang N., Orsida B., Whitford H., et al. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. Thorax 55 1 (Jan 2000) 53-59
41. Reynaud-Gaubert M., Marin V., Thirion X., Farnarier C., Thomas P., Badier M., et al. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration. J Heart Lung Transplant 21 7 (Jul 2002) 721-730
42. Barnes P.J. New treatments for chronic obstructive pulmonary disease. Ann Ist Super Sanita 39 4 (2003) 573-582
43. de Boer W.I. Cytokines and therapy in COPD: a promising combination?. Chest 121 5 Suppl (May 2002) 209S-218S
44. de Boer W.I. Perspectives for cytokine antagonist therapy in COPD. Drug Discov Today 10 2 (Jan 15 2005) 93-106
45. Wang S., Xu F., and Chen Y. Detection and significance of interleukin-8, 6, tumor necrosis factor-alpha in sputa from patients with chronic obstructive pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi 23 8 (Aug 2000) 465-467
46. Yamamoto C., Yoneda T., Yoshikawa M., Fu A., Tokuyama T., Tsukaguchi K., et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 112 2 (Aug 1997) 505-510
47. Ghanei M., and Harandi A.A. Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol 19 5 (May 2007) 451-456
48. Ghanei M., Tazelaar H.D., Chilosi M., Harandi A.A., Peyman M., Akbari H.M., et al. An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients. Respir Med (Mar 11 2008)
49. Ghanei M., Khalili A.R., Arab M.J., Mojtahedzadeh M., Aslani J., Lessan-Pezeshki M., et al. Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas-induced chronic bronchitis. Basic Clin Pharmacol Toxicol 97 5 (Nov 2005) 302-305